Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | URBN | HIMS |
|---|---|---|
| Price | $80.25 | $29.47 |
| Change today | ▼ 1.65% | ▼ 0.67% |
| Market cap | $6.87B | $6.88B |
| Return, 3 months | +18.0% | -18.5% |
| Return, year to date | +6.6% | -9.2% |
| Return, 1 year | +14.6% | -46.2% |
| P/E (TTM) | 12.6 | -46.0 |
| P/B | 2.4 | 21.2 |
| P/E percentile vs own 5y | 38th | 20th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.4% | +38.2% |
| Net profit growth (YoY) | +67.3% | -303.0% |
| Gross margin | 37.5% | 68.4% |
| Operating margin | 11.3% | -6.0% |
| Net margin | 8.8% | -5.5% |
| Return on equity | 20.9% | -32.0% |
| Analyst target vs. price | +15.0% | +17.5% |
| Analyst buy share | 55% | 27% |
| RSI (14) | 59 | 53 |
| 30-day volatility | 40.8% | 60.6% |
| Max drawdown, 1 year | -26.3% | -76.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
